Ramesh Chadalavada, MD
Pulmonary Disease Physician in Springfield, Tennessee.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Ramesh Chadalavada, MD filed 3,995 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in Springfield, Tennessee, prescribing 0% generic.
- 4K
- Part D claims, 2023
- 0%
- generic prescribing
- $835.32
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Ramesh Chadalavada, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
3,995 Top 9% higher than 91% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Ramesh Chadalavada, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Ramesh Chadalavada, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Tennessee
How Pulmonary Disease Physician compares to other specialties among Tennessee providers
Pulmonary Disease Physician ranks #78 among Tennessee's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Tennessee provider total, by primary NUCC taxonomy. The highlighted bar is Pulmonary Disease Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Ramesh Chadalavada, MD appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding MD credentials at 221 NORTHCREST DR, Springfield, TN, 37172, with a listed phone of (615) 384-2149. NPI 1487723342 was issued on 11/07/2006.
Medicare Part D records for calendar year 2023 show 3,995 prescription claims written by this provider, covering 567 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 57% brand-name and 0% generic by claim count.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487723342 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 11/07/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Ramesh Chadalavada, MD's current license status, disciplinary history, and board certifications with the Tennessee Board of Medical Examiners in Tennessee before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1487723342 is the unique 10-digit identifier CMS uses to link Chadalavada across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ramesh Chadalavada, MD. Source: openpaymentsdata.cms.gov.
Total received
$835
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
57% brand-name claims vs 0% generic, on 3,995 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,899
- Total Day Supply
- 130,157
- Brand vs Generic
- 57% brand / 0% generic
- Brand Drug Cost
- $1.8M
- Antibiotic Claims
- 219
Patient Demographics
- Average Patient Age
- 71.1 years
- Avg HCC Risk Score
- 1.92
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 106, 65-74: 256, 75-84: 171, 85+: 34
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Ramesh Chadalavada, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
1,058 claims
- Trelegy Ellipta
Trelegy Ellipta
625 claims
- Anoro Ellipta 336
Anoro Ellipta
336 claims
- Prednisone 306
Prednisone
306 claims
- Breo Ellipta 152
Breo Ellipta
152 claims
- Spiriva Respimat 144
Spiriva Respimat
144 claims
- Symbicort 131
Symbicort
131 claims
- Breztri Aerosphere 129
Breztri Aerosphere
129 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,058 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 625 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 336 |
| Prednisone | 306 |
| Breo Ellipta Fluticasone/Vilanterol | 152 |
| Spiriva Respimat Tiotropium Bromide | 144 |
| Symbicort Budesonide/Formoterol Fumarate | 131 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 129 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 128 |
| Cefdinir | 117 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Ramesh Chadalavada, MD fits within the Pulmonary Disease Physician landscape nationally.
Ramesh Chadalavada, MD's 3,995 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Tennessee
Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as Chadalavada.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Tennessee medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Tennessee
Frequently Asked Questions
What is Ramesh Chadalavada, MD's specialty? ▼
How much does Ramesh Chadalavada, MD prescribe under Medicare Part D? ▼
Where is Ramesh Chadalavada, MD located? ▼
What is Ramesh Chadalavada, MD's NPI number? ▼
Does Ramesh Chadalavada, MD prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does Ramesh Chadalavada, MD prescribe most often? ▼
Does Ramesh Chadalavada, MD accept Medicare? ▼
How can I verify Ramesh Chadalavada, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology